PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-87.96%
Negative net income growth while USLM stands at 31.99%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
7.30%
D&A growth well above USLM's 0.17%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-100.97%
Negative yoy deferred tax while USLM stands at 60.60%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-4.76%
Negative yoy SBC while USLM is 57.89%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-464.98%
Both reduce yoy usage, with USLM at -157.46%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-434.04%
Both yoy AR lines negative, with USLM at -168.28%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-443.95%
Both reduce yoy inventory, with USLM at -163.74%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-1952.85%
Negative yoy AP while USLM is 268.62%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-9.89%
Negative yoy usage while USLM is 127.57%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-33.77%
Negative yoy while USLM is 3437.06%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-135.43%
Both yoy CFO lines are negative, with USLM at -1.49%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
3.25%
Lower CapEx growth vs. USLM's 50.22%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-940.57%
Negative yoy acquisition while USLM stands at 47.17%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-142.62%
Negative yoy purchasing while USLM stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-100.00%
We reduce yoy sales while USLM is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-828.00%
We reduce yoy other investing while USLM is 47.17%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-182.29%
We reduce yoy invests while USLM stands at 50.98%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-37.70%
We cut debt repayment yoy while USLM is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
100.00%
Issuance growth of 100.00% while USLM is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
46.04%
Buyback growth at 50-75% of USLM's 85.37%. Martin Whitman questions partial disadvantage in per-share enhancements if competitor repurchases more.